References
1. Abarca J, Colon LR, Wang VS, Malone DC, Murphy JE, Armstrong EP (2006) Evaluation of the performance of drug-drug interaction screening software in community and hospital pharmacies. Journal of Managed Care Pharmacy 12 (5):383-389
2. Abarca J, Malone DC, Armstrong EP, Grizzle AJ, Hansten PD, Van Bergen RC, Lipton RB (2004) Concordance of severity ratings provided in four drug interaction compendia. Journal of the American Pharmacists Association : JAPhA 44 (2):136-141
3. Anthony M, Romero K, Malone DC, Hines LE, Higgins L, Woosley RL (2009) Warfarin interactions with substances listed in dru g information compendia and in the FDA-approved label for warfarin sodium. Clinical pharmacology and therapeutics 86 (4):425-429
4. Bertoli R, Bissig M, Caronzolo D, Odorico M, Pons M, Bernasconi E (2010) Assessment of potential drug-drug interactions at hospital discharge.
Swiss Medical Weekly 140 (JULY)
5. Bias TE, Venugopalan V, Berkowitz LB, Cha A (2014) Incidence of antiretroviral drug interactions during hospital course: The role of a pharmacist-led antiretroviral stewardship program. Journal of Pharmacy Technology 30 (2):48-53
6. Bista D, Saha A, Mishra P, Palaian S, Shankar PR (2009) Impact of educational intervention on the pattern and incidence of potential drug-drug interactions in Nepal. Pharmacy Practice 7 (4):242-247
7. Bleich GW, Bleich A, Chiamulera P, Sanches AC, Schneider DS, Teixeira JJ (2009) Frequency of potential interactions between drugs in medical prescriptions in a city in southern Brazil. Sao Paulo medical journal = Revista paulista de medicina 127 (4):206-210
8. Boyce RD, Collins C, Clayton M, Kloke J, Horn JR (2012) Inhibitory metabolic drug interactions with newer psychotropic drugs: inclusion in package inserts and influences of concurrence in drug interaction screening software. The Annals of pharmacotherapy 46 (10):1287-1298
9. Bravo AER, Tchambaz L, Krählenbühl-Melcher A, Hess L, Schlienger RG, Krähenbühl S (2005) Prevalence of Potentially Severe Drug-Drug
Interactions in Ambulatory Patients with Dyslipidaemia Receiving HMG-CoA Reductase Inhibitor Therapy. Drug Safety 28 (3):263-275
10. Chan A, Ng TR, Yap KY (2012) Clinically-relevant anticancer-antidepressant drug interactions. Expert opinion on drug metabolism & toxicology
8 (2):173-199
11. Clauson KA, Seamon MJ, Clauson AS, Van TB (2004) Evaluation of drug information databases for personal digital assistants. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 61 (10):1015-1024
12. Cruciol-Souza JM, Thomson JC (2006) A pharmacoepidemiologic study of drug interactions in a Brazilian teaching hospital. Clinics (Sao Paulo,
Brazil) 61 (6):515-520
13. Dhingra S, Parle M (2011) Assessment of drug interaction of antidepressants with other prescribed drugs. Asian Journal of Pharmaceutical and
Clinical Research 4 (SUPPL. 1):102-104
14. Doan J, Zakrzewski-Jakubiak H, Roy J, Turgeon J, Tannenbaum C (2013) Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy (Prevalencia y riesgo potencial de interacciones medicamentosas mediadas por el citocromo P450 en pacientes ancianos polimedicados hospitalizados.). Annals of Pharmacotherapy 47 (3):324-332
15. Doubova Dubova SV, Reyes-Morales H, Torres-Arreola Ldel P, Suarez-Ortega M (2007) Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City. BMC health services research 7:147
16. Egger SS, Drewe J, Schlienger RG (2003) Potential drug-drug interactions in the medication of medical patients at hospital discharge. Eur J Clin
Pharmacol 58 (11):773-778
17. Enders SJ, Enders JM, Holstad SG (2002) Drug-information software for Palm operating system personal digital assistants: breadth, clinical dependability, and ease of use. Pharmacotherapy 22 (8):1036-1040
18. Eyal S, Rasaby S, Ekstein D (2014) Concomitant therapy in people with epilepsy: Potential drug-drug interactions and patient awareness.
Epilepsy and Behavior 31:369-376
19. Far E, Curkovic I, Byrne K, Roos M, Egloff I, Dietrich M, Kirch W, Kullak-Ublick GA, Egbring M (2012) Validation of a transparent decision model to rate drug interactions. BMC Pharmacology and Toxicology 13 (7)
20. Fernandez de Palencia Espinosa MA, Diaz Carrasco MS, Fuster Soler JL, Ruiz Merino G, De la Rubia Nieto MA, Espuny Miro A (2014)
Pharmacoepidemiological study of drug-drug interactions in onco-hematological pediatric patients. International Journal of Clinical Pharmacy 36
(6):1160-1169
21. Fokter N, Mozina M, Bvrar M (2010) Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments. Wiener Klinische Wochenschrift 122 (3-4):81-88
22. Franz CC, Egger S, Born C, Ratz Bravo AE, Krahenbuhl S (2012) Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis. Eur J Clin Pharmacol 68 (2):179-188
23. Fritz D, Ceschi A, Curkovic I, Huber M, Egbring M, Kullak-Ublick GA, Russmann S (2012) Comparative evaluation of three clinical decision support systems: Prospective screening for medication errors in 100 medical inpatients. European Journal of Clinical Pharmacology 68 (8):1209-1219
24. Fulda TR, Valuck RJ, Zanden JV, Parker S, Byrns PJ (2000) Disagreement Among Drug Compendia on Inclusion and Ratings of Drug-Drug
Interactions. Current Therapeutic Research 61 (8):540-548
25. Gaddis GM, Holt TR, Woods M (2002) Drug interactions in at-risk emergency department patients. Academic Emergency Medicine 9 (11):1162-
1167
26. Guastaldi RB, Reis AM, Figueras A, Secoli SR (2011) Prevalence of potential drug-drug interactions in bone marrow transplant patients. Int J
Clin Pharm 33 (6):1002-1009
27. Hines LE, Ceron-Cabrera D, Romero K, Anthony M, Woosley RL, Armstrong EP, Malone DC (2011) Evaluation of warfarin drug interaction listings in US product information for warfarin and interacting drugs. Clinical therapeutics 33 (1):36-45
28. Ismail M, Iqbal Z, Khan MI, Javaid A, Arsalan H, Farhadullah, Khan F, Khan AZ, Nasir F, Khan JA (2013) Frequency, levels and predictors of potential drug-drug interactions in a pediatrics ward of a teaching hospital in Pakistan. Tropical Journal of Pharmaceutical Research 12 (3):401-406

29. Ismail M, Iqbal Z, Khattak MB, Javaid A, Khan MI, Khan TM, Asim SM (2012) Potential drug-drug interactions in psychiatric ward of a tertiary care hospital: Prevalence, levels and association with risk factors. Tropical Journal of Pharmaceutical Research 11 (2):289-296
30. Ismail M, Iqbal Z, Khattak MB, Khan MI, Arsalan H, Javaid A, Gul Q, Khan F (2013) Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan. International Journal of Clinical Pharmacy 35 (3):455-462
31. Jacob JE, Wagner ML, Sage JI, Dalmady-Israel C, Edouard B (2003) Safety of selegiline with cold medications. Annals of Pharmacotherapy 37
(3):438-441
32. Johnston SS, Udall M, Cappelleri JC, Johnson BH, Shrady G, Chu BC, Silverman SL (2014) Potential drug-drug and drug-condition interactions among fibromyalgia patients initiating pregabalin or duloxetine: Prevalence and health care expenditure impact. Pain Medicine (United States) 15
(8):1282-1293
33. Kashyap M, D'Cruz S, Sachdev A, Tiwari P (2013) Drug-drug interactions and their predictors: Results from Indian elderly inpatients. Pharmacy
Practice 11 (4):191-195
34. Kohler GI, Bode-Boger SM, Busse R, Hoopmann M, Welte T, Boger RH (2000) Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. International journal of clinical pharmacology and therapeutics 38 (11):504-513
35. Langdorf MI, Fox JC, Marwah RS, Montague BJ, Hart MM (2000) Physician versus computer knowledge of potential drug interactions in the emergency department. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 7 (11):1321-1329
36. Lima RE, De Bortoli Cassiani SH (2009) Potential drug interactions in intensive care patients at a teaching hospital. Revista latino-americana de enfermagem 17 (2):222-227
37. Lin CF, Wang CY, Bai CH (2011) Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study. Drugs & aging 28 (3):219-225
38. Malone DC, Abarca J, Hansten PD, Grizzle AJ, Armstrong EP, Van Bergen RC, Duncan-Edgar BS, Solomon SL, Lipton RB (2004) Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions. Journal of the American Pharmacists Association :
JAPhA 44 (2):142-151
39. Mark TL, Joish VN, Hay JW, Sheehan DV, Johnston SS, Cao Z (2011) Antidepressant use in geriatric populations: The burden of side effects and interactions and their impact on adherence and costs. American Journal of Geriatric Psychiatry 19 (3):211-221
40. Martins MA, Carlos PP, Ribeiro DD, Nobre VA, Cesar CC, Rocha MO, Ribeiro AL (2011) Warfarin drug interactions: a comparative evaluation of the lists provided by five information sources. Eur J Clin Pharmacol 67 (12):1301-1308
41. Metzke B, Hug MJ, Fink G, Hieke S, Jung M, Engelhardt M (2012) Drug-drug interactions in the hematology and oncology department: A reallife assessment of frequency and severity. Blood 120 (21)
42. Miller CD, El-Kholi R, Faragon JJ, Lodise TP (2007) Prevalence and risk factors for clinically significant drug interactions with antiretroviral therapy. Pharmacotherapy 27 (10):1379-1386
43. Mirosevic Skvrce N, Macolic Sarinic V, Mucalo I, Krnic D, Bozina N, Tomic S (2011) Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study. Croatian medical journal 52 (5):604-
614
44. Miyasaka LS, Atallah AN (2003) Risk of drug interaction: combination of antidepressants and other drugs. Revista de saude publica 37 (2):212-
215
45. Murphy JE, Malone DC, Olson BM, Grizzle AJ, Armstrong EP, Skrepnek GH (2009) Development of computerized alerts with management strategies for 25 serious drug-drug interactions. American journal of health-system pharmacy : AJHP : official journal of the American Society of
Health-System Pharmacists 66 (1):38-44
46. Nesar S, Shoaib MH, Yousuf RI, Rahim N, Muhammad IN (2014) Incidence of medication error associated with the use of beta-blockers in
Pakistan. Pakistan Journal of Pharmaceutical Sciences 27 (3):531-536
47. Obreli Neto PR, Nobili A, de Lyra DP, Jr., Pilger D, Guidoni CM, de Oliveira Baldoni A, Cruciol-Souza JM, de Carvalho Freitas AL, Tettamanti
M, Gaeti WP, Nakamura Cuman RK (2012) Incidence and predictors of adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical
Sciences, Societe canadienne des sciences pharmaceutiques 15 (2):332-343
48. Obreli Neto PR, Nobili A, Marusic S, Pilger D, Guidoni CM, Baldoni Ade O, Cruciol-Souza JM, Da Cruz AN, Gaeti WP, Cuman RK (2012)
Prevalence and predictors of potential drug-drug interactions in the elderly: a cross-sectional study in the brazilian primary public health system.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 15 (2):344-354
49. Olvey EL, Clauschee S, Malone DC (2010) Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendia. Clinical pharmacology and therapeutics 87 (1):48-51
50. Patel VK, Acharya LD, Rajakannan T, Surulivelrajan M, Guddattu V, Padmakumar R (2011) Potential drug interactions in patients admitted to cardiology wards of a south Indian teaching hospital. The Australasian medical journal 4 (1):9-14
51. Perkins NA, Murphy JE, Malone DC, Armstrong EP (2006) Performance of drug-drug interaction software for personal digital assistants. The
Annals of pharmacotherapy 40 (5):850-855
52. Phansalkar S, Desai AA, Bell D, Yoshida E, Doole J, Czochanski M, Middleton B, Bates DW (2012) High-priority drug-drug interactions for use in electronic health records. Journal of the American Medical Informatics Association : JAMIA 19 (5):735-743
53. Polen HH, Zapantis A, Clauson KA, Jebrock J, Paris M (2008) Ability of online drug databases to assist in clinical decision-making with infectious disease therapies. BMC infectious diseases 8:153
54. Polidori P, Di Giorgio C, Provenzani A (2012) Incidence of potential drug interactions in a transplant centre setting and relevance of electronic alerts for clinical practice support. Informatics in primary care 20 (4):257-262
55. Pote S, Tiwari P, D'Cruz S (2007) Medication prescribing errors in a public teaching hospital in India: A prospective study. Pharmacy Practice 5
(1):17-20
56. Purdy BD, Raymond AM, Lesar TS (2000) Antiretroviral prescribing errors in hospitalized patients. The Annals of pharmacotherapy 34 (7-
8):833-838
57. Ramos GV, Guaraldo L, Japiassu AM, Bozza FA (2014) Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care. Journal of Clinical Pharmacy and Therapeutics 40 (1):63-67
58. Reis AM, Cassiani SH (2010) Evaluation of three brands of drug interaction software for use in intensive care units. Pharmacy world & science :
PWS 32 (6):822-828
59. Reis AMM, Cassiani SHB (2011) Prevalence of potential drug interactions in patients in an intensive care unit of a university hospital in Brazil.
Clinics 66 (1):9-15
60. Roughead EE, Kalisch LM, Barratt JD, Gilbert AL (2010) Prevalence of potentially hazardous drug interactions amongst Australian veterans.
British journal of clinical pharmacology 70 (2):252-257

61. Saylor MS, Smetana RF (2011) Potential for drug-drug interactions in treating cancer-related nausea and distress. Journal of Oncology Pharmacy
Practice 17 (4):403-408
62. Secoli SR, Figueras A, Lebrao ML, de Lima FD, Santos JL (2010) Risk of potential drug-drug interactions among Brazilian elderly: a populationbased, cross-sectional study. Drugs & aging 27 (9):759-770
63. Sharma S, Chhetri HP, Alam K (2014) A study of potential drug-drug interactions among hospitalized cardiac patients in a teaching hospital in
Western Nepal. Indian Journal of Pharmacology 46 (2):152-156
64. Skvrce NM, Sarinic VM, Krnic D, Tomic S, Mucalo I, Bozina N (2011) Identifying adverse drug reactions associated with drug-drug interactions:
Comparison of data mining of spontaneous reporting databases. Drug Safety 34 (10):910
65. Smithburger PL, Kane-Gill SL, Benedict NJ, Falcione BA, Seybert AL (2010) Grading the severity of drug-drug interactions in the intensive care unit: A comparison between clinician assessment and proprietary database severity rankings. Annals of Pharmacotherapy 44 (11):1718-1724
66. Smithburger PL, Kane-Gill SL, Seybert AL (2010) Drug-drug interactions in cardiac and cardiothoracic intensive care units: An analysis of patients in an academic medical centre in the US. Drug Safety 33 (10):879-888
67. Smithburger PL, Kane-Gill SL, Seybert AL (2012) Drug-drug interactions in the medical intensive care unit: an assessment of frequency, severity and the medications involved. The International journal of pharmacy practice 20 (6):402-408
68. Straubhaar B, Krahenbuhl S, Schlienger RG (2006) The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge. Drug Saf 29 (1):79-90
69. Teixeira JJ, Crozatti MT, dos Santos CA, Romano-Lieber NS (2012) Potential drug-drug interactions in prescriptions to patients over 45 years of age in primary care, southern Brazil. PLoS One 7 (10):e47062. doi:10.1371/journal.pone.0047062
70. Teklay G, Shiferaw N, Legesse B, Bekele ML (2014) Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: A prospective observational study. Thrombosis Journal 12 (1)
71. Venturini CD, Engroff P, Ely LS, de Araujo Zago LF, Schroeter G, Gomes I, de Carli GA, Morrone FB (2011) Gender differences, polypharmacy, and potential pharmacological interactions in the elderly. Clinics 66 (11):1867-1872
72. Vitry AI (2007) Comparative assessment of four drug interaction compendia. British journal of clinical pharmacology 63 (6):709-714.
73. Vonbach P, Dubied A, Krahenbuhl S, Beer JH (2008) Evaluation of frequently used drug interaction screening programs. Pharmacy World and
Science 30 (4):367-374
74. Wang LM, Wong M, Lightwood JM, Cheng CM (2010) Black box warning contraindicated comedications: Concordance among three major drug interaction screening programs. Annals of Pharmacotherapy 44 (1):28-34
75. Yap KYL, Tay WL, Chui WK, Chan A (2011) Clinically relevant drug interactions between anticancer drugs and psychotropic agents. European
Journal of Cancer Care 20 (1):6-32
76. Yi-Lwern Yap K, Raaj S, Chan A (2010) OncoRx-IQ: A tool for quality assessment of online anticancer drug interactions. International Journal for Quality in Health Care 22 (2):93-106
77. Bacic-Vrca V, Marusic S, Erdeljic V, Falamic S, Gojo-Tomic N, Rahelic D (2010) The incidence of potential drug-drug interactions in elderly patients with arterial hypertension. Pharmacy World and Science 32 (6):815-821
78. Clauson KA, Marsh WA, Polen HH, Seamon MJ, Ortiz BI (2007) Clinical decision support tools: analysis of online drug information databases.
BMC medical informatics and decision making 7:7. doi:10.1186/1472-6947-7-7
79. Cornu P, Steurbaut S, Sostaric S, Mrhar A, Dupont AG (2014) Performance of a clinical decision support system and of clin ical pharmacists in preventing drug-drug interactions on a geriatric ward. International Journal of Clinical Pharmacy 36 (3):519-525
80. Dirin M, Mousavi S, Afshari A, Tabrizian K, Ashrafi M (2014) Potential drug-drug interactions in prescriptions dispensed in community and hospital pharmacies in East of Iran. Journal of Research in Pharmacy Practice 3 (3):104-107
81. Gholaminezhad S, Hadjibabaie M, Gholami K, Javadi MR, Radfar M, Karimzadeh I, Ghavamzadeh A (2014) Pattern and associated factors of potential drug-drug interactions in both pre- and early post-hematopoietic stem cell transplantation stages at a referral center in the Middle East.
Annals of hematology 93 (11):1913-1922
82. Greene M, Steinman MA, McNicholl IR, Valcour V (2014) Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection. Journal of the American Geriatrics Society 62 (3):447-453
83. Hadjibabaie M, Badri S, Ataei S, Moslehi AH, Karimzadeh I, Ghavamzadeh A (2013) Potential drug-drug interactions at a referral hematologyoncology ward in Iran: A cross-sectional study. Cancer Chemotherapy and Pharmacology 71 (6):1619-1627
84. Kornblith A, Heard K (2011) Reliability and validity of 5 databases for the identification of warfarin-medication interactions. Clinical and
Applied Thrombosis/Hemostasis 17 (6):E95-E97
85. Kupferberg N, Jones Hartel L (2004) Evaluation of five full-text drug databases by pharmacy students, faculty, and librarians: do the groups agree? Journal of the Medical Library Association : JMLA 92 (1):66-71
86. Marusic S, Bacic-Vrca V, Obreli Neto PR, Franic M, Erdeljic V, Gojo-Tomic N (2013) Actual drug-drug interactions in elderly patients discharged from internal medicine clinic: A prospective observational study. European Journal of Clinical Pharmacology 69 (9):1717-1724
87. Moriel P, Siqueira JA, Carnevale RC, Rezende Costa CG, da Cruz AA, da Silva NMO, Bernardes AC, Carvalho RP, Mazzola PG (2013) Drug interactions in female oncologic inpatients: Differences among databases (Interacoes medicamentosas em mulheres internadas com cancer:
Diferencas entre bases de dados.). Revista de Ciencias Farmaceuticas Basica e Aplicada 34 (3):333-337
88. Patel N, Abdelsayed S, Veve M, Miller CD (2011) Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens. Annals of Pharmacotherapy 45
(3):317-324
89. Pervaiz F, Khan MZU, Azhar S, Hussain A, Masood J, Nisa ZU, Khan MA, Murtaza G (2014) Prevalence of potential drug-drug interactions in cancer patients at cancer hospitals in Pakistan. Latin American Journal of Pharmacy 33 (7):1159-1166
90. Roblek T, Trobec K, Mrhar A, Lainscak M (2014) Potential drug-drug interactions in hospitalized patients with chronic heart failure and chronic obstructive pulmonary disease. Archives of Medical Science 10 (5):920-932
91. Sanchez Munoz-Torrero JF, Barquilla P, Velasco R, Fernandez Capitan MDC, Pacheco N, Vicente L, Chicon JL, Trejo S, Zamorano J, Lorenzo
Hernandez A (2010) Adverse drug reactions in internal medicine units and associated risk factors. European Journal of Clinical Pharmacology 66
(12):1257-1264
92. Vasudev A, Harrison R (2008) Prescribing safely in elderly psychiatric wards: Survey of possible drug interactions. Psychiatric Bulletin 32
(11):417-418
93. Vegh A, Lanko E, Fittler A, Vida RG, Miseta I, Takacs G, Botz L (2014) Identification and evaluation of drug-supplement interactions in
Hungarian hospital patients. International Journal of Clinical Pharmacy 36 (2):451-459
94. Yiu P, Nguyen NN, Holodniy M (2011) Clinically significant drug interactions in younger and older human immunodeficiency virus-positive patients receiving antiretroviral therapy. Pharmacotherapy 31 (5):480-489

95. Gavronski M, Hartikainen S, Zharkovsky A (2012) Analysis of potential interactions between warfarin and prescriptions in Estonian outpatients aged 50 years or more (Analisis de las interacciones potenciales entre warfarina y medicamentos prescritos en pacientes ambulatorios mayores de 50 anos en Estonia.). Pharmacy Practice 10 (1):9-16
96. Mendes-Netto RS, Silva CQV, Filho ADO, Rocha CE, Lyra-Junior DP (2011) Assessment of drug interactions in elderly patients of a family health care unit i Aracaju (Brazil): A pilot study. African Journal of Pharmacy and Pharmacology 5 (7):812-818
97. Rentero Redondo L, Iniesta Navalon C, Urbieta Sanz E, Garcia Molina C, Trujillano Ruiz A, Cabello Muriel A (2013) Improvement strategy on drug interactions in hospital environment. Atencion Farmaceutica 15 (4):237-243
98. Strandell J, Caster O, Bate A, Noren N, Edwards IR (2011) Reporting patterns indicative of adverse drug interactions: a systematic evaluation in
VigiBase. Drug Saf 34 (3):253-266
99. Barrons R (2004) Evaluation of personal digital assistant software for drug interactions. American Journal of Health-System Pharmacy 61
(4):380-385
100. Dallenbach MF, Bovier PA, Desmeules J (2007) Detecting drug interactions using personal digital assistants in an out-patient clinic. Qjm 100
(11):691-697
101. Lubinga SJ, Uwiduhaye E (2011) Potential drug-drug interactions on in-patient medication prescriptions at Mbarara Regional Referral Hospital
(MRRH) in western Uganda: prevalence, clinical importance and associated factors. African health sciences 11 (3):499-507
102. Ray S, Pramanik J, Bhattacharyya M, Todi S (2010) Prospective observational evaluation of incidences and implications of drug-drug interactions induced adverse drug reactions in critically ill patients. Indian journal of pharmaceutical sciences 72 (6):787-792
103. Strain JJ, Chiu NM, Brodsky M, Karim A, Caliendo G (2002) Comparison of three methods for identifying medical drug-psychotropic drug interactions. General hospital psychiatry 24 (5):311-315
104. Sutton J, Stockton L, McCord G, Gilchrist VJ, Fedyna D (2004) Handheld computer use in a family medicine clerkship. Academic medicine : journal of the Association of American Medical Colleges 79 (11):1114-1119
105. Chatsisvili A, Sapounidis I, Pavlidou G, Zoumpouridou E, Karakousis VA, Spanakis M, Teperikidis L, Niopas I (2010) Potential drug-drug interactions in prescriptions dispensed in community pharmacies in Greece. Pharmacy World and Science 32 (2):187-193
106. Gottlieb A, Stein GY, Oron Y, Ruppin E, Sharan R (2012) INDI: a computational framework for inferring drug interactions and their associated recommendations. Molecular systems biology 8:592
107. Iyer SV, Harpaz R, LePendu P, Bauer-Mehren A, Shah NH (2014) Mining clinical text for signals of adverse drug-drug interactions. Journal of the American Medical Informatics Association : JAMIA 21 (2):353-362
108. Kulkarni V, Bora SS, Sirisha S, Saji M, Sundaran S (2013) A study on drug-drug interactions through prescription analysis in a South Indian teaching hospital. Therapeutic Advances in Drug Safety 4 (4):141-146
109. Okuno MF, Cintra RS, Vancini-Campanharo CR, Batista RE (2013) Drug interaction in the emergency service. Einstein (Sao Paulo, Brazil) 11
(4):462-466
110. Pinto MCX, Malaquias DP, Ferre F, Pinheiro MLP (2013) Potentially inappropriate medication use among institutionalized elderly individuals in southeastern brazil. Brazilian Journal of Pharmaceutical Sciences 49 (4):709-717
111. Vilar S, Uriarte E, Santana L, Tatonetti NP, Friedman C (2013) Detection of Drug-Drug Interactions by Modeling Interaction Profile
Fingerprints. PLoS ONE 8 (3)
112. Neto VC, Garcia VP, Helena ETS (2010) Possible pharmacological interactions in hypertensive and/or diabetic elderly in family health units at
Blumenau (SC). Brazilian Journal of Pharmaceutical Sciences 46 (4):795-804
113. Oshikoya KA, Oreagba IA, Ogunleye OO, Lawal S, Senbanjo IO (2013) Clinically significant interactions between antiretroviral and coprescribed drugs for HIV-infected children: Profiling and comparison of two drug databases. Therapeutics and Clinical Risk Management 9 (1):215-
221
114. Patel P, Rana D, Suthar J, Malhotra S, Patel V (2014) A study of potential adverse drug-drug interactions among prescribed drugs in medicine outpatient department of a tertiary care teaching hospital. Journal of Basic and Clinical Pharmacy 5 (2):44-48
115. Cheng F, Zhao Z (2014) Machine learning-based prediction of drug-drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties. Journal of the American Medical Informatics Association : JAMIA 21 (e2):e278-286
116. Sun J, Zhao M, Fanous AH, Zhao Z (2013) Characterization of schizophrenia adverse drug interactions through a network approach and drug classification. BioMed research international 2013:458989
117. Tari L, Anwar S, Liang S, Cai J, Baral C (2010) Discovering drug-drug interactions: a text-mining and reasoning approach based on properties of drug metabolism. Bioinformatics (Oxford, England) 26 (18):i547-553
118. Vilar S, Harpaz R, Uriarte E, Santana L, Rabadan R, Friedman C (2012) Drug-drug interaction through molecular structure similarity analysis.
Journal of the American Medical Informatics Association 19 (6):1066-1074